We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer.
- Authors
Al Assaad, Majd; Gundem, Gunes; Liechty, Benjamin; Sboner, Andrea; Medina, Juan; Papaemmanuil, Elli; Sternberg, Cora N.; Marks, Asher; Souweidane, Mark M.; Greenfield, Jeffrey P.; Tran, Ivy; Snuderl, Matija; Elemento, Olivier; Imielinski, Marcin; Pisapia, David J.; Miguel Mosquera, Juan
- Abstract
Pilocytic astrocytomas are the most common pediatric brain tumors, typically presenting as low-grade neoplasms. We report two cases of pilocytic astrocytoma with atypical tumor progression. Case 1 involves a 12-yr-old boy with an unresectable suprasellar tumor, negative for BRAF rearrangement but harboring a BRAF p.V600E mutation. He experienced tumor size reduction and stable disease following dabrafenib treatment. Case 2 describes a 6-yr-old boy with a thalamic tumor that underwent multiple resections, with no actionable driver detected using targeted next-generation sequencing. Whole-genome and RNA-seq analysis identified an internal tandem duplication in FGFR1 and RAS pathway activation. Future management options include FGFR1 inhibitors. These cases demonstrate the importance of escalating molecular diagnostics for pediatric brain cancer, advocating for early reflexing to integrative whole-genome sequencing and transcriptomic profiling when targeted panels are uninformative. Identifying molecular drivers can significantly impact treatment decisions and improve patient outcomes.
- Subjects
MOLECULAR diagnosis; BRAIN death in children; TUMORS; CANCER invasiveness; WHOLE genome sequencing
- Publication
Cold Spring Harbor Molecular Case Studies, 2023, Vol 9, Issue 4, p1
- ISSN
2373-2873
- Publication type
Article
- DOI
10.1101/mcs.a006275